For years, it has been a formidable subject of interest in preclinical studies for its potential to accelerate healing and recovery processes
The Peptide Revolution: Why BPC-157 Is Getting the Spotlight The Modern Wellness Movement and the Rise of Peptides Over the past few years, the global health and wellness space has shifted toward more innovative, science-based solutions
Meto's Perspective: What We Think Patients Deserve to Know At Meto, our clinical focus is on metabolic and hormonal health the kind of deep, root-cause medicine that requires real diagnostics, physician oversight, and evidence-based treatment protocols
In September 2023, FDA placed "Thymosin Beta-4, Fragment (LKKTETQ)," the substance sold as TB-500, on Category 2 of its interim 503A bulk drug substances list, meaning FDA identified significant safety concerns and would not permit licensed compounding pharmacies to use it
Be gentle when cleaning your skin